CuraLife Ltd
About
Company description
We are CuraLife, an international consumer healthcare company founded in 2013.
We are an innovative company with one main focus: Improving the metabolic well-being of people worldwide, through nutraceuticals solutions now used for years by hundreds of thousands of consumers, supported by high-quality clinical studies.
We develop smart devices and AI applications to simplify personal health journeys to live life at fullest. Our technologies are driven from our consumer intelligence, creating points of interaction with our users. We create personalized health journeys
for each and every individual.
Our key product, curalin, is a premium Herbal Dietary Supplement with proven efficacy in promoting a healthy glycemic response, energy levels and metabolism of carbs and fats. CuraLin has a unique formula, composed by 9 natural ingredients which is the result of more than 4 years of R&D.
According to published randomized, double-blind, placebo-controlled clinical evidence CuraLin is a safe and effective add-on therapy to first-line oral antidiabetes drugs in patients with diagnosed Type-2 Diabetes, especially in cases where those fail to achieve adequate glycemic control.
We are looking for partners in new markets which share the company's vision & values, and can benefit from the unique unit economics of the business: premium positioning, high retention, high frequency and growing impact.
We invite you to join us on our mission to transform an industry and help millions of individuals around the world live a higher quality of life.
Quick facts
Sales markets | Africa; Asia; Eastern Europe; Middle East; North America; Western Europe |
---|---|
Primary business activity | Manufacturer: Finished Food Products |
Affiliated categories: | Botanical Extracts |Branded Finished Products |Food Supplements / Nutraceuticals More |
Recently at
Vitafoods Europe Online and In-Person
1 - 12 May 2023 - Online We were at stand L295, N303 See our Exhibitor Profile See full Exhibitor ListNews about CuraLife Ltd
17 Mar 2023
Curalin Randomized, Double-blind, Placebo Controlled Clinical Trial published in Diabetes Metabolism Research and Reviews
According to a Double-blind, Placebo Controlled Clinical Trial published in Diabetes Metabolism Research and Reviews, curalin is well-tolerated and significantly reduces HbA1c.
Read more17 Mar 2023
The study of curalin as add-on therapy in adults with type 2 diabetes mellitus
Published news announcing Curalife starting the clinical study testing curalin as add-on therapy in adults with type 2 diabetes mellitus
Read more15 Mar 2023
Curalife signs exclusive distribution agreement for Malaysia and Singapore
Curalife signs exclusive distribution agreement for Malaysia and Singapore with LYC Healthcare. Find out more.
Read more